InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by Melo John, Chairman & CEO. Director active across 1 companies, notably AMYRIS, INC.. Cumulatively, 6 disclosures have been recorded. Total volume traded: €2.5m. The latest transaction was disclosed on 7 July 2021 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations6 total
€1m95,115 shares@ €13.167359.4% of flow
Common Stock
SEC:0000899243-21-028017·
€1m95,115 shares@ €13.167329.7% of flow
Common Stock
SEC:0000899243-21-028017:0·
€855,83373,572 shares@ €11.632640.6% of flow
Common Stock
SEC:0001365916-21-000046·
€855,83373,572 shares@ €11.632620.3% of flow
Common Stock
SEC:0001365916-21-000046:0·
0149,365 shares0
Common Stock
SEC:0001365916-21-000035·
0149,365 shares0
Common Stock
SEC:0001365916-21-000035:0·
6 of 6 declarations
About Melo John
John Melo is the President and CEO at Amyris, Inc. In this role, he is responsible for the strategic and operational direction of the company. Melo plays a key role in making decisions that influence the future direction of the organization. His expertise in biotechnology and management is essential for the success of the company.
